Pa Shun International Holdings Past Earnings Performance
Past criteria checks 2/6
Pa Shun International Holdings has been growing earnings at an average annual rate of 6.7%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been declining at an average rate of 48.9% per year.
Key information
6.7%
Earnings growth rate
7.8%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | -48.9% |
| Return on equity | n/a |
| Net Margin | 1.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Pa Shun International Holdings Limited (HKG:574) Shares May Have Slumped 33% But Getting In Cheap Is Still Unlikely
Feb 18
Investors Aren't Buying Pa Shun International Holdings Limited's (HKG:574) Revenues
Dec 19Is Pa Shun International Holdings (HKG:574) Using Debt In A Risky Way?
Apr 05Pa Shun International Holdings (HKG:574) Has Debt But No Earnings; Should You Worry?
Sep 05Is Pa Shun International Holdings (HKG:574) Using Too Much Debt?
May 24Read This Before Selling Pa Shun International Holdings Limited (HKG:574) Shares
Dec 15
Revenue & Expenses Breakdown
How Pa Shun International Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 129 | 2 | 31 | 0 |
| 30 Sep 23 | 125 | -16 | 27 | 0 |
| 30 Jun 23 | 121 | -34 | 23 | 0 |
| 31 Mar 23 | 97 | -39 | 21 | 0 |
| 31 Dec 22 | 72 | -43 | 19 | 0 |
| 30 Sep 22 | 71 | -186 | 21 | 0 |
| 30 Jun 22 | 71 | -328 | 24 | 0 |
| 31 Mar 22 | 78 | -329 | 26 | 0 |
| 31 Dec 21 | 86 | -330 | 28 | 0 |
| 30 Sep 21 | 175 | -373 | 29 | 0 |
| 30 Jun 21 | 265 | -416 | 31 | 0 |
| 31 Mar 21 | 370 | -417 | 33 | 0 |
| 31 Dec 20 | 475 | -418 | 34 | 0 |
| 30 Sep 20 | 563 | -313 | 35 | 0 |
| 30 Jun 20 | 652 | -207 | 35 | 0 |
| 31 Mar 20 | 748 | -200 | 41 | 0 |
| 31 Dec 19 | 845 | -194 | 46 | 0 |
| 30 Sep 19 | 850 | -128 | 57 | 0 |
| 30 Jun 19 | 855 | -63 | 67 | 0 |
| 31 Mar 19 | 838 | -61 | 69 | 0 |
| 31 Dec 18 | 821 | -59 | 70 | 0 |
| 30 Sep 18 | 861 | -26 | 64 | 0 |
| 30 Jun 18 | 900 | 8 | 58 | 0 |
| 31 Mar 18 | 885 | 9 | 56 | 0 |
| 31 Dec 17 | 870 | 10 | 55 | 0 |
| 30 Sep 17 | 877 | -3 | 57 | 0 |
| 30 Jun 17 | 884 | -16 | 59 | 0 |
| 31 Mar 17 | 872 | -4 | 62 | 0 |
| 31 Dec 16 | 861 | 8 | 66 | 0 |
| 30 Sep 16 | 821 | 23 | 64 | 0 |
| 30 Jun 16 | 780 | 39 | 63 | 0 |
| 31 Mar 16 | 824 | 64 | 71 | 0 |
| 31 Dec 15 | 868 | 88 | 79 | 0 |
| 30 Sep 15 | 882 | 99 | 83 | 0 |
| 30 Jun 15 | 896 | 109 | 88 | 0 |
| 31 Mar 15 | 872 | 77 | 85 | 0 |
| 31 Dec 14 | 847 | 46 | 83 | 0 |
| 31 Dec 13 | 794 | 63 | 62 | 0 |
Quality Earnings: 574 has a large one-off loss of CN¥8.4M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 574 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 574 has become profitable over the past 5 years, growing earnings by 6.7% per year.
Accelerating Growth: 574 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 574 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (2.2%).
Return on Equity
High ROE: 574's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.